优化晚期帕金森病的器械辅助治疗：挑战性场景下持续皮下注射阿扑吗啡的病例系列 - Suppr

Optimizing Device-Aided Therapies in Advanced Parkinson's Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios.

作者信息

De Leon Adrian Paul R, Bhidayasiri Roongroj, Phokaewvarangkul Onanong

机构信息

Chulalongkorn Center of Excellence for Parkinson's Disease and Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

Department of Neurology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.

出版信息

J Mov Disord. 2025 Jul;18(3):285-288. doi: 10.14802/jmd.25045. Epub 2025 May 14.

DOI:10.14802/jmd.25045

PMID:40368423

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12301942/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef02/12301942/170719dd2b16/jmd-25045f1.jpg

相似文献

Optimizing Device-Aided Therapies in Advanced Parkinson's Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios.

J Mov Disord. 2025 Jul;18(3):285-288. doi: 10.14802/jmd.25045. Epub 2025 May 14.

Licensed Subcutaneous Infusion Therapies in Advanced Parkinson's Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis.

Neurol Ther. 2025 Jul 8. doi: 10.1007/s40120-025-00789-9.

Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review.

Mov Disord Clin Pract. 2023 Jun 26;10(9):1253-1267. doi: 10.1002/mdc3.13810. eCollection 2023 Sep.

Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS-Park Cohort.

Mov Disord Clin Pract. 2025 Jul 17. doi: 10.1002/mdc3.70240.

Advanced Parkinson's disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study.

Neurodegener Dis Manag. 2025 Apr-Jun;15(2-3):65-76. doi: 10.1080/17582024.2025.2481818. Epub 2025 Mar 24.

Profile of People With Parkinson's Disease Treated With a Device-Aided Therapy in Spain. A Comparative Multicenter Observational Study.

Mov Disord Clin Pract. 2025 Jul 24. doi: 10.1002/mdc3.70239.

Cognitive outcomes of infusion therapies in Parkinson's disease: A comprehensive systematic review.

Parkinsonism Relat Disord. 2025 Sep;138:107950. doi: 10.1016/j.parkreldis.2025.107950. Epub 2025 Jul 10.

Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.

CNS Drugs. 2022 Dec;36(12):1269-1283. doi: 10.1007/s40263-022-00963-9. Epub 2022 Nov 21.

Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease: A Structured Review.

J Parkinsons Dis. 2021;11(2):475-489. doi: 10.3233/JPD-202348.

EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.

Mov Disord. 2015 Apr;30(4):510-6. doi: 10.1002/mds.26067. Epub 2014 Nov 10.

本文引用的文献

What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience.

J Neural Transm (Vienna). 2024 Nov;131(11):1307-1320. doi: 10.1007/s00702-024-02782-2. Epub 2024 May 15.

Increasing Serotonin to Reduce Parkinsonian Tremor.

Front Syst Neurosci. 2021 Jul 20;15:682990. doi: 10.3389/fnsys.2021.682990. eCollection 2021.

Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations.

CNS Drugs. 2019 Sep;33(9):905-918. doi: 10.1007/s40263-019-00661-z.

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.

Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses.

Clin Neuropharmacol. 2015 May-Jun;38(3):89-103. doi: 10.1097/WNF.0000000000000082.

The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study.

Clin Neuropharmacol. 2009 Sep-Oct;32(5):266-8. doi: 10.1097/WNF.0b013e3181a6a92b.

A randomized trial of winged Vialon cannulae and metal butterfly needles.

Int J Palliat Nurs. 2000 Mar;6(3):110-6. doi: 10.12968/ijpn.2000.6.3.8937.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Optimizing Device-Aided Therapies in Advanced Parkinson's Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios.

作者信息

De Leon Adrian Paul R, Bhidayasiri Roongroj, Phokaewvarangkul Onanong

机构信息

Department of Neurology, Jose R. Reyes Memorial Medical Center, Manila, Philippines.

出版信息

J Mov Disord. 2025 Jul;18(3):285-288. doi: 10.14802/jmd.25045. Epub 2025 May 14.

DOI:10.14802/jmd.25045

PMID:40368423

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12301942/

Abstract

摘要

相似文献

Optimizing Device-Aided Therapies in Advanced Parkinson's Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios.

J Mov Disord. 2025 Jul;18(3):285-288. doi: 10.14802/jmd.25045. Epub 2025 May 14.

Licensed Subcutaneous Infusion Therapies in Advanced Parkinson's Disease: An Indirect Treatment Comparison and Cost-Minimisation Analysis.

Neurol Ther. 2025 Jul 8. doi: 10.1007/s40120-025-00789-9.

Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review.

Mov Disord Clin Pract. 2023 Jun 26;10(9):1253-1267. doi: 10.1002/mdc3.13810. eCollection 2023 Sep.

Subcutaneous Apomorphine Infusion Initiation Is Associated with Impulse Control Disorder Attenuation in Advanced Parkinson's Disease Patients: Insights from the French NS-Park Cohort.

Mov Disord Clin Pract. 2025 Jul 17. doi: 10.1002/mdc3.70240.

Advanced Parkinson's disease and eligibility for device-aided therapies in Morocco: a multicenter cross-sectional study.

Neurodegener Dis Manag. 2025 Apr-Jun;15(2-3):65-76. doi: 10.1080/17582024.2025.2481818. Epub 2025 Mar 24.

Profile of People With Parkinson's Disease Treated With a Device-Aided Therapy in Spain. A Comparative Multicenter Observational Study.

Mov Disord Clin Pract. 2025 Jul 24. doi: 10.1002/mdc3.70239.

Cognitive outcomes of infusion therapies in Parkinson's disease: A comprehensive systematic review.

Parkinsonism Relat Disord. 2025 Sep;138:107950. doi: 10.1016/j.parkreldis.2025.107950. Epub 2025 Jul 10.

Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.

CNS Drugs. 2022 Dec;36(12):1269-1283. doi: 10.1007/s40263-022-00963-9. Epub 2022 Nov 21.

Cost-Effectiveness of Device-Aided Therapies in Parkinson's Disease: A Structured Review.

J Parkinsons Dis. 2021;11(2):475-489. doi: 10.3233/JPD-202348.

EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.

Mov Disord. 2015 Apr;30(4):510-6. doi: 10.1002/mds.26067. Epub 2014 Nov 10.

本文引用的文献

What was first and what is next in selecting device-aided therapy in Parkinson's disease? Balancing evidence and experience.

J Neural Transm (Vienna). 2024 Nov;131(11):1307-1320. doi: 10.1007/s00702-024-02782-2. Epub 2024 May 15.

Increasing Serotonin to Reduce Parkinsonian Tremor.

Front Syst Neurosci. 2021 Jul 20;15:682990. doi: 10.3389/fnsys.2021.682990. eCollection 2021.

Apomorphine for Parkinson's Disease: Efficacy and Safety of Current and New Formulations.

CNS Drugs. 2019 Sep;33(9):905-918. doi: 10.1007/s40263-019-00661-z.

Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.

Effective delivery of apomorphine in the management of Parkinson disease: practical considerations for clinicians and Parkinson nurses.

Clin Neuropharmacol. 2015 May-Jun;38(3):89-103. doi: 10.1097/WNF.0000000000000082.

The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study.

Clin Neuropharmacol. 2009 Sep-Oct;32(5):266-8. doi: 10.1097/WNF.0b013e3181a6a92b.

A randomized trial of winged Vialon cannulae and metal butterfly needles.

Int J Palliat Nurs. 2000 Mar;6(3):110-6. doi: 10.12968/ijpn.2000.6.3.8937.

Optimizing Device-Aided Therapies in Advanced Parkinson's Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Optimizing Device-Aided Therapies in Advanced Parkinson's Disease: A Case Series on Continuous Subcutaneous Apomorphine Infusion in Challenging Scenarios.

作者信息

机构信息

出版信息

相似文献

本文引用的文献